Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
01/2009
01/28/2009EP2019093A1 Urea type cinnamide derivative
01/28/2009EP2018872A1 Pharmaceutical product
01/28/2009EP2018378A2 Heterocyclic inhibitors of 11-b hydroxyl steroid dehydrogenase type i and methods of using the same
01/28/2009EP2018367A1 Novel microbiocides
01/28/2009CN101356161A Heterocyclic CETP inhibitors
01/27/2009US7482466 Hydroxamates as therapeutic agents
01/27/2009US7482379 protease inhibitors more specifically to peptide inhibitors of cysteine proteases; viral infections, stroke, neurodegenerative disease, inflammatory diseases,autoimmune diseases like lupus, cancer; alpha aza-amino acid residues; prevent proteolysis
01/27/2009CA2389280C Triazoles as farnesyl transferase inhibitors
01/27/2009CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
01/22/2009WO2009011850A2 Novel therapeutic compounds
01/22/2009WO2009010991A2 Purification process to prepare highly pure anastrozole
01/22/2009US20090023734 Treating cell proliferative disorders
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/22/2009US20090023228 Dual-acting Imidazole antihypertensive agents
01/15/2009WO2009009179A2 Non-invasive molecular imaging of cellular histone deacetylase substrate using magnetic resonance spectroscopy (mrs) or positron emission tomography (pet)
01/15/2009WO2009007534A2 Spin transition material
01/15/2009WO2008125342A3 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
01/15/2009US20090018150 5-Ht2b Receptor Antagonists
01/15/2009US20090018056 Heteroarylcarbamoylbenzene derivatives
01/15/2009CA2690138A1 Spin transition material
01/14/2009EP2013169A1 Indole amide derivatives as ep4 receptor antagonists
01/14/2009CN101346350A Method for production of heteroaromatic ring compound having n-rf group
01/14/2009CN100451007C compound containing aromatic ether and ditriazole and use thereof
01/14/2009CN100451006C Carboxyl acylamide compound and its preparing method and use
01/13/2009US7476743 Treating cellular proliferation disease with 1,2,5-triazol-5-one and as an anticancer agent and inhibitor of kinesins for treatment of hyperplasia or restenosis
01/13/2009US7476688 Cyclic amidine derivatives
01/08/2009WO2009005381A1 The novel chiral triazole derivatives, synthesis and application thereof
01/08/2009WO2009005076A1 Amide compound
01/08/2009US20090012304 preparation of intermediates 3-[3-(4-methyl-5-methylsulfanyl-4H-[1,2,4]triazol-3-ylmethyl)phenoxy]-5-difluoromethyl-benzonitrile derivatives; for making enzyme inhibitors of HIV-1 reverse transcriptase, treating AIDS and HIV-1 syndromes
01/08/2009US20090009061 Composition for Conductive Materials Comprising Crosslinkable Arylamine Compounds and Use Thereof in Electronic Devices and Electronic Equipment
01/08/2009CA2692265A1 Amide compounds
01/07/2009EP2011853A1 Lubricating oil additive, lubricating oil composition containing the same, various low-friction sliding members, rolling bearing, and sliding bearing
01/07/2009EP1562589B1 Diaminotriazoles useful as inhibitors of protein kinases
01/07/2009CN101337944A P-38 kinase inhibitors
01/07/2009CN100448844C Inhibitors of histone deacetylase
01/06/2009US7473700 To treat fever, pain, and inflammation; Cyclooxygenase (COX-2) Inhibitors; Less side effects; 4-(3-mercapto-5-phenyl-1,2,4-triazole-1-yl)-benzenesulfonamide
01/06/2009US7473280 Coloring agent compositions and methods of treating keratin fibers therewith
01/06/2009CA2494321C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
01/01/2009US20090005410 N-(4-Chloro-2-[1,2,3]triazolo[4,5-b]pyridin-1-yl-phenyl)-4-(1-hydroxy-1-methyl-ethyl)-benzene-sulfonamide sodium salt, used as chemokine receptors antagonists, useful for treating inflammation
12/2008
12/31/2008WO2009001942A1 Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound, and method for production of isoxazoline compound
12/31/2008WO2009000775A1 Post-screening labeling of on-bead compounds
12/31/2008EP2007745A2 Fungicide n-cyclopropyl-sulfonylamide derivatives
12/31/2008EP1769071A4 Proteomic analysis
12/31/2008CN101333196A 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
12/31/2008CN100447137C P-38 kinase inhibitors
12/31/2008CA2690191A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008US7470716 Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions
12/25/2008US20080319201 N[S(4-ARYL-TRIAZOL-3-YL)alpha-MERCAPTOACETYL] -P-AMINO BENZOIC ACIDS AS HIV REVERSE TRANSCRIPTASE INHIBITORS
12/25/2008US20080319059 Caffeic Acid Derivative and Composition Containing the Same
12/25/2008US20080319037 1,2,4-triazol-1-yl bisphenyl derivatives for use in the treatment of endocrine-dependent tumors
12/24/2008WO2008157407A2 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia
12/24/2008WO2008157162A1 Dipeptide analogs as coagulation factor inhibitors
12/24/2008WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
12/24/2008WO2008156092A1 Azolylmethylidenehydrazine derivative and use thereof
12/24/2008EP2004601A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
12/24/2008CN100445272C Non-steroidal (hetero) cyclically substd. acylanilides with mixed gestagen and androgen activity
12/24/2008CN100445271C Amide derivative
12/24/2008CA2692170A1 Azolylmethylidenehydrazine derivative and use thereof
12/23/2008US7468459 Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation
12/23/2008US7468393 Diarylsulfones as 5-HT2A antagonists
12/23/2008US7468385 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide
12/23/2008US7468212 Organic electroluminescent device
12/23/2008CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity
12/18/2008WO2008151437A1 Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
12/18/2008WO2008130321A3 Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
12/18/2008WO2008130319A3 Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain
12/18/2008WO2008118391A3 Triazinone and diazinone derivatives useful as hsp90 inhibitors
12/18/2008WO2008103574A3 Peroxisome proliferator activated receptor modulators
12/18/2008US20080312272 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
12/18/2008US20080311136 Triazole-Containing Releasable Linkers, Conjugates Thereof, and Methods of Preparation
12/18/2008CA2727528A1 Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
12/17/2008EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/17/2008CN101323601A Triazole derivatives useful in therapy
12/17/2008CN101323600A Triadimefon and triadimenol compounds having antimicrobial activity, salts, synthetic methods and uses thereof
12/16/2008US7465804 3-[p-(substituted benzyloxy)- or p-(substituted -5-thiazolylmethoxy)phenyl]propionic acid derivatives in which the propionic acid is 3-substituted with a carbamoyl-, imidazolyl-, triazolyl-, tetrazolyl-, or oxazolyl group; activating G-protein coupled receptor 40; treatment of type II diabetes
12/16/2008US7465749 The impurity isoletrozole is more rapidly oxidized to 4,4'-dicyanobenzophenone than Letrozole, which can be seperated by crystallization to yield highly purified letrozole
12/16/2008CA2302937C Method for producing (hetero)aromatic hydroxylamines
12/11/2008WO2008150444A1 Inhibition of hiv-1 infection by potent metallocene conjugated peptide through conformational entrapment of envelope gp120
12/11/2008WO2008148840A1 Piperidine/piperazine derivatives
12/11/2008WO2008148468A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
12/11/2008CA2689985A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
12/11/2008CA2687912A1 Piperidine/piperazine derivatives
12/10/2008EP2000465A1 Triazolone derivative
12/10/2008EP1998761A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/10/2008EP1094816B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/09/2008US7462619 Pyridazine, pyrimidine and pyrazine ethyne compounds
12/09/2008CA2309051C Sulfamoyl compounds and agricultural and horticultural fungicides
12/04/2008WO2008147764A1 Mmp inhibitors and methods of use thereof
12/04/2008WO2008147763A1 Mmp inhibitors and methods of use thereof
12/04/2008WO2008147671A2 Glycerol derivatives and methods of making same
12/04/2008WO2008145842A2 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof
12/04/2008WO2008145563A2 Process for preparing triazolones
12/04/2008WO2008144933A1 Cinnamoyl inhibitors of transglutaminase
12/04/2008US20080300348 Polymer
12/04/2008US20080299639 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation
12/04/2008US20080299080 Thiophene analogues for the treatment or prevention of flavivirus infections
12/04/2008CA2687770A1 Process for preparing triazolones
12/03/2008EP1997492A1 Method of treatment
12/02/2008US7459565 Reacting 4-halomethylbenzonitrile with 4-amino-1,2,4-triazole to give 4-[(4-amino-4H-1,2,4-triazolium-1-yl)methyl]benzonitrile halide (may be purified by leeching); deaminating product to form 4-[1-(1H-1,2,4-triazol-1-yl)methylene]benzonitrile, which is reacted with p-fluorobenzonitrile; alcohol solvent
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 178